Abstract
Autosomal dominant nonautoimmune hyperthyroidism (ADNAH) is caused by gain of function mutations in the TSH receptor (TSHr) gene and characterized by toxic thyroid hyperplasia with a variable age of onset in the absence of thyroid antibodies and clinical symptoms of autoimmune thyroid disease in at least two generations. We report here a Turkish family with a novel TSHr gene mutation with distinct features all consistent with ADNAH. Thyroid function tests of the proband were as follows: free T3: 13.1 pg/ml (N: 1.8–4.6); free T4: 5.1 ng/dl (N: 0.9–1.7); TSH: 0.01 μIU/ml (N: 0.2–4.2); and TSH receptor antibody: 2 IU/ml (N: 0–10). A heterozygous missense mutation in exon 10 of the TSHr gene (c.1454C>T) resulting in the substitution of valine for alanine at codon 485 (p.Ala485Val) was found in the father and his son and daughter. This mutation had arisen de novo in the father. Functional studies of the novel TSHr germline mutation demonstrated a higher constitutive activation of adenyl cyclase than wild type without any effect on phospholipase C activity. In conclusion, our data indicate that gain of function germline mutations in the TSHr gene should be investigated in families with members suffering from thyrotoxicosis and progressive growth of goiter, but without clinical and biochemical evidence of autoimmune thyroid disease. In addition, patients harboring the same mutation of the TSHr gene may show wide phenotypic variability with respect to the age at onset, and severity of hyperthyroidism and thyroid growth.
Similar content being viewed by others
Abbreviations
- ADNAH:
-
Autosomal dominant nonautoimmune hyperthyroidism
- Ala:
-
Alanine
- hTg:
-
Human thyroglobuline
- IP:
-
Inositol phosphate
- PCR:
-
Polymerase chain reaction
- SNPs:
-
Single nucleotide polymorphisms
- T4:
-
Thyroxine
- T3:
-
Triiodothyronine
- TPO:
-
Thyroid peroxidase
- TRAb:
-
TSH receptor antibody
- TSH:
-
Thyroid stimulating hormone
- TSHr:
-
TSH receptor
- Val:
-
Valine
References
Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G, Persani L (2001) A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 145:249–254
Al-Khafaji F, Wiltshire M, Fuhrer D, Mazziotti G, Lewis MD, Smith PJ, Ludgate M (2005) Biological activity of activating thyrotropin receptor mutants: modulation by iodide. J Mol Endocrinol 34:209–220
Arturi F, Chiefari E, Tumino S, Russo D, Squatrito S, Chazenbalk G, Persani L, Rapoport B, Filetti S (2002) Similarities and differences in the phenotype of members of an Italian family with hereditery non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation. J Endocrinol Invest 25:696–701
Borgel K, Pohlenz J, Koch HG, Bramswig JH (2005) Long-term carbimazole treatment of neonatal nonautoimmune hyperthyroidism due to a new activating TSH receptor gene mutation (Ala428Val). Horm Res 64:203–208
Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297–7301
Camacho P, Gordon D, Chiefari E, Yong S, De Jong S, Pitale S, Russo D, Filetti S (2000) A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid 10:1009–1012
Claus M, Maier J, Paschke R, Kujat C, Stumwoll M, Fuhrer D (2005) Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditery nonautoimmune hyperthyroidism. Thyroid 15:1089–1094
Corvilain B, Van Sande J, Dumont JE, Vassart G (2001) Somatic and germline mutations of the TSH receptor and thyroid disease. Clin Endocrinol 55:143–158
Costagliola S, Khoo D, Vassart G (1998) Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor. FEBS Lett 436:427–433
Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J (1994) Germline mutations in the thyrotropin receptor gene cause nonautoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396–401
Fuhrer D, Lachmund P, Nebel IT, Paschke R (2003) The thyrotropin receptor mutation database: update 2003. Thyroid 13:1123–1126
Fuhrer D, Lewis MD, Alkhafaji F, Starkey K, Paschke D, Wynford-Thomas D, Eggo M, Ludgate M (2003) Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology 144:4018–4030
Fuhrer D, Mix M, Wonerow P, Richter I, Willgerodt H, Paschke R (1999) Variable phenotype associated with Ser505Asn-activating thyrotropin-receptor germline mutation. Thyroid 9:757–761
Fuhrer D, Wonerow P, Willgerodt H, Paschke R (1997) Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234–4238
Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T (1998) Severe congenital hyperthyroidism caused by a germ-line neomutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431–1436
Harries LW, Wickham CL, Evans JC, Rule SA, Joyner MV, Ellard S (2005) Analysis of haematopoietic chimaerism by quantitative real-time polymerase chain reaction. Bone Marrow Transplant 35:283–290
Holzapfel HP, Wonerow P, Petrykowski W, Henschen M, Scherbaum WA, Paschke R (1997) Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 82:3879–3884
Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G (1995) Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 332:150–154
Lavard L, Sehested A, Brock JB, Muller J, Perrild H, Feldt-Rasmussen U, Parma J, Vassart G (1999) Long-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr). Horm Res 51:43–46
Nwosu BU, Gourgiotis L, Gershengorn MC, Neumann S (2006) A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as a cause of hereditary nonautoimmune hyperthyroidism. Thyroid 16:505–512
Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G (1995) Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3’,5’-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol 9:725–733
Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E, Misrahi M (1996) A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81:2023–2026
Schwab KO, Gerlich M, Broecker M, Sohlemann P, Derwahl M, Lohse MJ (1997) Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 131:899–904
Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S (2003) Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J 22:2692–2703
Thomas JL, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC (1982) Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Copenh) 100:512–518
Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszevski P, Portmann L, Dumont JE, Vassart G, Parma J (1996) Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547–554
Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT, Ellard S (2004) Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol 60:711–716
Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J, Vassart G (1995) Genetic basis of endocrine disease: somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577–2585
Vassart G (2006) Thyroid-stimulating hormone receptor mutations. In: DeGroot LJ, Jameson JL (eds) Endocrinology. Elsevier Saunders, Philadelphia, pp 2191–2199
Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S (2002) Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736–746
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akcurin, S., Turkkahraman, D., Tysoe, C. et al. A family with a novel TSH receptor activating germline mutation (p.Ala485Val). Eur J Pediatr 167, 1231–1237 (2008). https://doi.org/10.1007/s00431-007-0659-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0659-9